Trace Amine Associated Receptor 8 (TAAR8) (AA 51-150) antibody (Cy5.5)
Quick Overview for Trace Amine Associated Receptor 8 (TAAR8) (AA 51-150) antibody (Cy5.5) (ABIN1412603)
Target
See all Trace Amine Associated Receptor 8 (TAAR8) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 51-150
-
Predicted Reactivity
- Human,Mouse,Rat,Cow,Sheep,Pig,Rabbit
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human G protein coupled receptor 102
-
Isotype
- IgG
-
-
-
-
Application Notes
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- Trace Amine Associated Receptor 8 (TAAR8)
-
Alternative Name
- GPR102/TAAR8
-
Background
-
Synonyms: G protein coupled receptor 102, G-protein coupled receptor 102, GPR102, TA5, TAAR8, TAAR8_HUMAN, TaR-5, TaR-8, TAR5, Trace amine assiciated receptor 8, Trace amine receptor 5, Trace amine receptor 8, Trace amine-associated receptor 8, TRAR5, GPCR GPR102.
Background: Trace amines are endogenous molecules structurally related to classical biogenic amines that are linked to psychiatric conditions. A family of G-protein coupled receptors referred to as trace-amine-associated receptors (TAAR) are activated by trace amines and are present in very low levels in mammalian tissue. TaRs contain several structural features that are similar to the rhodopsin -adrenergic receptor superfamily, including the positions of the seven transmembrane regions that provide common ligand-binding pockets as well as the short N- and C-terminal domains. TAAR proteins are potential targets for drugs of abuse, such as amphetamine and MDMA, as well as neuropsychiatric disorders including schizophrenia, depression, and attention deficit disorder.
Target
-